Mixed evidence over Echinacea being useful treatment for colds

Image
ANI Washington
Last Updated : Feb 24 2014 | 1:05 PM IST

A new study has found that for people seeking a natural treatment for the common cold, some preparations containing the plant Echinacea work better than nothing, yet "evidence is weak".

The evidence review revealed no significant reductions in preventing illness, but didn't rule out "small preventive effects."

The six authors conducted reviews on this subject in 1998, 2006 and 2008 and wanted to do an update to include several new trials conducted since then.

"We've been doing this for so long and are very familiar with past research- which has been mixed from the very beginning," author Bruce Barrett, M.D., Ph.D. in the department of family medicine at the University of Wisconsin in Madison, said.

The research team reviewed 24 randomized controlled trials to determine whether Echinacea was a safe and effective cold prevention and treatment.

Trials included 4631 participants and 33 preparations, along with placebo. Echinacea products studied in these trials varied widely according to characteristics of three different plant species, the part of the plant used and method of manufacturing.

Barrett added that "it looks like taking Echinacea may reduce the incidence of colds. For those who take it as a treatment, some of the trials report real effects-but many do not. Bottom line: Echinacea may have small preventive or treatment effects, but the evidence is mixed."

The study was published in the journal Cochrane Library.

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Feb 24 2014 | 12:53 PM IST

Next Story